Exploring the unexplored: identifying knowledge gaps in novel pharmacological treatments for diabetic retinopathy.
作者信息
Sharifan Amin, Sivaprasad Sobha
机构信息
Department for Evidence-based Medicine and Evaluation, University for Continuing Education Krems, Krems an der Donau, Austria.
NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UK.
出版信息
Eye (Lond). 2025 Jan;39(1):192-194. doi: 10.1038/s41433-024-03349-x. Epub 2024 Sep 17.
Abstract
摘要
相似文献
1
Exploring the unexplored: identifying knowledge gaps in novel pharmacological treatments for diabetic retinopathy.探索未知领域：识别糖尿病视网膜病变新型药物治疗中的知识空白。
Eye (Lond). 2025 Jan;39(1):192-194. doi: 10.1038/s41433-024-03349-x. Epub 2024 Sep 17.
2
Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and meta-analysis.抗血管内皮生长因子药物与激光光凝术治疗糖尿病性视网膜病变的比较：一项系统评价和荟萃分析。
Health Technol Assess. 2024 Dec 11:1-71. doi: 10.3310/PCGV5709.
3
Anti-VEGF drugs compared with laser photocoagulation for the treatment of proliferative diabetic retinopathy: a systematic review and individual participant data meta-analysis.抗血管内皮生长因子药物与激光光凝术治疗增殖性糖尿病视网膜病变的比较：一项系统评价和个体参与者数据荟萃分析
Health Technol Assess. 2025 Apr 2:1-75. doi: 10.3310/MJYP6578.
4
Fenofibrate for diabetic retinopathy.非诺贝特治疗糖尿病性视网膜病变。
Cochrane Database Syst Rev. 2023 Jun 13;6(6):CD013318. doi: 10.1002/14651858.CD013318.pub2.
5
Aspirin in diabetic retinopathy. A systematic review.
Endocrinol Metab Clin North Am. 2002 Sep;31(3):779-93. doi: 10.1016/s0889-8529(02)00017-8.
6
Blood pressure control for diabetic retinopathy.糖尿病视网膜病变的血压控制。
Cochrane Database Syst Rev. 2023 Mar 28;3(3):CD006127. doi: 10.1002/14651858.CD006127.pub3.
7
Prevalence of Diabetic Retinopathy in Indigenous and Non-Indigenous Australians: A Systematic Review and Meta-analysis.澳大利亚原住民和非原住民糖尿病视网膜病变的患病率：系统评价与荟萃分析
Ophthalmology. 2023 Jan;130(1):56-67. doi: 10.1016/j.ophtha.2022.07.024. Epub 2022 Aug 2.
8
A systematic literature review of machine learning based risk prediction models for diabetic retinopathy progression.基于机器学习的糖尿病视网膜病变进展风险预测模型的系统文献回顾。
Artif Intell Med. 2023 Sep;143:102617. doi: 10.1016/j.artmed.2023.102617. Epub 2023 Jun 26.
9
Pentoxifylline for diabetic retinopathy.己酮可可碱用于治疗糖尿病视网膜病变。
Cochrane Database Syst Rev. 2008 Apr 16;2008(2):CD006693. doi: 10.1002/14651858.CD006693.pub2.
10
Pharmacological mechanism and clinical study of Qiming granules in treating diabetic retinopathy based on network pharmacology and literature review.基于网络药理学和文献回顾的芪明颗粒治疗糖尿病视网膜病变的药理机制及临床研究。
J Ethnopharmacol. 2023 Feb 10;302(Pt A):115861. doi: 10.1016/j.jep.2022.115861. Epub 2022 Nov 2.
引用本文的文献
1
SGLT2 inhibitors and diabetic retinopathy: Insights from the management of nephropathy.钠-葡萄糖协同转运蛋白2抑制剂与糖尿病视网膜病变：来自肾病管理的见解
Eye (Lond). 2025 Feb;39(2):213-214. doi: 10.1038/s41433-024-03472-9. Epub 2024 Nov 12.
本文引用的文献
1
An update on long-acting therapies in chronic sight-threatening eye diseases of the posterior segment: AMD, DMO, RVO, uveitis and glaucoma.后部阶段慢性致盲性眼病长效治疗的最新进展：AMD、DMO、RVO、葡萄膜炎和青光眼。
Eye (Lond). 2022 Jun;36(6):1154-1167. doi: 10.1038/s41433-021-01766-w. Epub 2022 Jan 1.
2
Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis.全球糖尿病视网膜病变的患病率及 2045 年预期负担的系统评价和荟萃分析。
Ophthalmology. 2021 Nov;128(11):1580-1591. doi: 10.1016/j.ophtha.2021.04.027. Epub 2021 May 1.
Zotero 插件